| Literature DB >> 29941852 |
Louise C Burgess1, Stuart M Phillips2, Thomas W Wainwright3.
Abstract
Nutritional supplements can influence outcomes for individuals undergoing major surgery, particularly in older persons whose functional reserve is limited. Accelerating recovery from total hip replacement (THR) and total knee replacement (TKR) may offer significant benefits. Therefore, we explored the role of nutritional supplements in improving recovery following THR and TKR. A systematic review was conducted to source randomized clinical trials that tested nutritional supplements in cohorts of THR or TKR patients. Our search yielded nine relevant trials. Intake of a carbohydrate-containing fluid is reported to improve insulin-like growth factor levels, reduce hunger, nausea, and length of stay, and attenuate the decrease in whole-body insulin sensitivity and endogenous glucose release. Amino acid supplementation is reported to reduce muscle atrophy and accelerate return of functional mobility. One paper reported a suppressive effect of beta-hydroxy beta-methylbutyrate, L-arginine, and L-glutamine supplementation on muscle strength loss following TKR. There is limited evidence for nutritional supplementation in THR and TKR pathways; however, the low risk profile and potential benefits to adjunctive treatment methods, such as exercise programs, suggest nutritional supplements may have a role. Optimizing nutritional status pre-operatively may help manage the surgical stress response, with a particular benefit for undernourished, frail, or elderly individuals.Entities:
Keywords: enhanced recovery after surgery; nutrition; orthopedics; total hip replacement; total knee replacement
Mesh:
Year: 2018 PMID: 29941852 PMCID: PMC6073268 DOI: 10.3390/nu10070820
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Inclusion and exclusion criteria for included studies.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Population | |
| Total hip replacement patients | Studies on animals |
| Total knee replacement patients | |
| Intervention | |
| Pre-operative or post-operative oral nutrition | Intravenous nutritional supplementation |
| Iron supplementation | |
| Outcome Measure | |
| Length of stay | |
| Post-operative complications | |
| Insulin resistance | |
| Pain | |
| Functionality | |
| C-reactive protein | |
| Vitamin D | |
| Methodology | |
| Randomized clinical trials | Review articles |
| Pilot randomized clinical trials | Case studies |
| Cross-sectional studies | |
| Historical studies | |
| Non-randomized clinical trials | |
| Publication | |
| Published in English | Unpublished studies |
| Access to full text | Study protocols |
Search strategy to source texts.
| Search Strategy | ||
|---|---|---|
| Operation | Timing | Topic |
| (“Arthroplasty, Replacement, Hip”) OR (“Hip Prosthesis”) | Preoperative OR pre-operative OR pre operative OR (“Preoperative Period”) | Nutriti* OR (MH “Dietary Carbohydrates”) OR Carbohydrat* OR (MH “Diet+”) OR Protein OR amino acids OR “branched chain amino acid” OR Glutamine OR |
THA—total hip arthroplasty; THR—total hip replacement; TKA—total knee arthroplasty; TKR—total knee replacement.
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Summary of studies included within review.
| Study | Design and Sample Size | Patient, Population. or Problem | Intervention, Prognostic | Comparison or Intervention | Outcomes | Main Findings |
|---|---|---|---|---|---|---|
| Dreyer et al., 2013 [ | RCT | TKR patients | 20 g of essential amino acids (EAA) twice daily between meals for 1 week before and 2 weeks after TKR. | Placebo supplementation (20 g (100% alanine) | Muscle atrophy, muscle strength, and functional mobility. | The placebo group exhibited greater quadriceps muscle atrophy (−14.3 ± 3.6% change) from baseline to 2 weeks post-surgery. EAAs also attenuated atrophy in the non-operated quadriceps and in the hamstring and adductor muscles of both extremities. The EAA group demonstrated better functional mobility at 2 and 6 weeks post-operatively (all |
| Nishizaki et al., 2015 [ | RCT | TKR patients | Beta-hydroxy beta-methylbutyrate (HMB; 2400 mg), | Control food (orange juice, 226 kcal of energy and 280 mg of protein) | Body weight, bilateral knee extension strength, rectus femoris cross-sectional area. | Maximal quadriceps strength was 1.1 ± 0.62 Nm/kg pre-surgery and 0.7 ± 0.9 Nm/kg 14 days post-surgery in the control group ( |
| Alito and de Aguilar-Nascimento 2016 [ | Pilot RCT | THR patients | 6 h pre-operative fasting for solids, an oral drink (200 mL of 12.5% maltodextrin) up to 2 h before induction of anesthesia, restricted intravenous fluids (only 1000 mL of cystalloid fluid after surgery), and pre-operative immune nutrition (600 mL/day of Impact—Nestle, Brazil) for 5 days prior to surgery. | Control group (traditional care, 6–8 h of pre-operative fasting, intravenous hydration until the 1st post-operative day and no pre-operative immune supplementation) | Length of stay, C-reactive protein. | Median length of stay (LOS) was 3 (2–5) days in the intervention group and 6 (3–8) days in controls ( |
| Aronsson et al., 2008 [ | Pilot RCT | THR patients | Carbohydrate-rich drink (an iso-osmolar carbohydrate-rich solution: 12.5 g carbohydrate/100 mL, pH 5.0) pre-operatively. | Placebo drink (flavored water) | IGF-1 and IGFBP-1 were determined in serum by RIA. Body composition was determined by dual energy X-ray absorptiometry (performed the day before surgery and at 6–8 weeks after surgery) | Compared to placebo, the authors found a relative increase in IGF-1 bioavailability post-operatively after a carbohydrate-rich drink given shortly before surgery. There were no significant differences in the changes in fat or lean body mass between groups ( |
| Hartsen et al., 2012 [ | RCT | ASA physical status I–III patients scheduled for THR | 400 mL of an oral 12.5% carbohydrate solution | Placebo drink (flavored water) | Visual analog scales were used to score six discomfort parameters. | Immediately after surgery, carbohydrate-treated patients were less hungry (median scores 9.5 vs. 22 mm) and experienced less nausea (0 vs. 1.5 mm) ( |
| Ljunggren and Hahn 2012 [ | RCT | THR patients | Tap Water: 800 mL by mouth, 2 h before entering the operating room OR | Fasting (no food or water from midnight before the surgery) | Intravenous glucose tolerance, physical stress, muscle catabolism, body fluid volumes, complications, wellbeing, and insulin sensitivity. | Pre-operative ingestion of tap water or a nutritional drink had no statistically significant effect on glucose clearance, insulin sensitivity, post-operative complications, or wellbeing in patients undergoing THR. |
| Nygren et al., 1999 [ | RCT | THR patients | Pre-operative oral iso-osmolar carbohydrate administration (800 mL 12.5% carbohydrates), the evening before the operation. Another 400 mL of the same beverage was allowed 2 h after midnight, taken no later than 2 h before the initiation of anesthesia. | Placebo drink | Insulin sensitivity | Patients given a carbohydrate drink shortly before elective surgery displayed less reduced insulin sensitivity (−16% (not significant)) after surgery compared to patients undergoing surgery after an overnight fast (37% |
| Soop et al., 2001 [ | RCT | THR patients | Carbohydrate-rich drink (12.5 g/100 mL carbohydrate, 12% monosaccharides, 12% disaccharides, 76% polysaacharides, 285 mosmol/kg), 800 mL between 7 p.m. and 12:00 a.m. on the evening before surgery and 400 mL on the morning of surgery. | Placebo drink (acesulfame-K, 0.64 g/100 mL citrate, 107 mosmol/kg) | Glucose, lactate and insulin concentrations, glycerol, NEFA, glucoregulatory hormone concentrations, glucose kinetics, and substrate utilization. | Whole-body insulin sensitivity decreased by 18% in the intervention group vs. 43% in the placebo group. This was attributable to a less reduced glucose disposal in peripheral tissues and increased glucose oxidation rates. |
| Soop et al., 2004 [ | RCT | THR patients | Carbohydrate rich drink (12.5 g /100 mL carbohydrate, 12% monosaccharides, 12% disaccharides, 76% polysaacharides, 285 mosm/kg, 800 mL between 7 p.m. and 12:00 a.m. on the evening before surgery and 400 mL on the morning of surgery. | Placebo drink | Glucose kinetics, substrate utilization, nitrogen balance, ambulation time, food consumption, and LOS. | Whole-body glucose disposal and nitrogen balance were similar between groups. Pre-operative carbohydrate treatment significantly attenuated post-operative endogenous glucose release (0.69 (0.07) vs. 1.21 (0.13) mg kg−1, ( |
RCT = Randomized Clinical Trial; IGF = Insulin like growth factor; IGFBP = Insulin like growth factor binding protein; RIA = Radioimmunoassay; ASA = American Society of Anesthesiologists; NEFA = nonesterified free fatty acid.